 AstraZeneca PLC ADRhedged (BATS:AZNH – Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 300 shares,  an increase of 200.0% from the September 30th total of 100 shares. Based on an average daily trading volume, of 5,300 shares, the short-interest ratio is currently 0.1 days. Approximately 0.5% of the shares of the stock are short sold. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 5,300 shares, the short-interest ratio is currently 0.1 days.
AstraZeneca PLC ADRhedged (BATS:AZNH – Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 300 shares,  an increase of 200.0% from the September 30th total of 100 shares. Based on an average daily trading volume, of 5,300 shares, the short-interest ratio is currently 0.1 days. Approximately 0.5% of the shares of the stock are short sold. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 5,300 shares, the short-interest ratio is currently 0.1 days. 
AstraZeneca PLC ADRhedged Stock Performance
AZNH stock opened at $50.27 on Thursday. AstraZeneca PLC ADRhedged has a 1-year low of $38.74 and a 1-year high of $50.92. The company’s 50 day moving average is $48.70 and its 200 day moving average is $44.74.
AstraZeneca PLC ADRhedged Company Profile
Further Reading
- Five stocks we like better than AstraZeneca PLC ADRhedged
- What Are Dividends? Buy the Best Dividend Stocks
- These 3 High-Momentum ETFs Are Riding the Tech Wave
- Trading Halts Explained
- Verizon Results Trigger Rebound in High-Yield Stock
- What is the MACD Indicator and How to Use it in Your Trading
- Picks & Shovels: Investing in the Physical Foundation of AI
Receive News & Ratings for AstraZeneca PLC ADRhedged Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca PLC ADRhedged and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						 
						